Japan Ai-based Clinical Trials Solution Provider Market Size & Outlook

The ai-based clinical trials solution provider market in Japan is expected to reach a projected revenue of US$ 52.4 million by 2030. A compound annual growth rate of 22.2% is expected of Japan ai-based clinical trials solution provider market from 2022 to 2030.
Revenue, 2021 (US$M)
$8.6
Forecast, 2030 (US$M)
$52.4
CAGR, 2022 - 2030
22.2%
Report Coverage
Japan

Japan ai-based clinical trials solution provider market, 2018-2030 (US$M)

Japan

Related Markets

Japan ai-based clinical trials solution provider market highlights

  • The Japan ai-based clinical trials solution provider market generated a revenue of USD 8.6 million in 2021 and is expected to reach USD 52.4 million by 2030.
  • The Japan market is expected to grow at a CAGR of 22.2% from 2022 to 2030.
  • In terms of segment, oncology was the largest revenue generating therapeutic applications in 2021.
  • CVD is the most lucrative therapeutic applications segment registering the fastest growth during the forecast period.


Ai-based clinical trials solution provider market data book summary

Market revenue in 2021USD 8.6 million
Market revenue in 2030USD 52.4 million
Growth rate22.2% (CAGR from 2021 to 2030)
Largest segmentOncology
Fastest growing segmentCVD
Historical data2018 - 2020
Base year2021
Forecast period2022 - 2030
Quantitative unitsRevenue in USD million
Market segmentationOncology, CVD, Neurological Diseases or conditions, Metabolic diseases, Infectious diseases
Key market players worldwideThe Carlyle Group Inc, Mendel.ai, Median Technologies, SAI.TECH Global Corp, Alphabet Inc Class A, Exscientia PLC ADR


Other key industry trends

  • In terms of revenue, Japan accounted for 0.7% of the global ai-based clinical trials solution provider market in 2021.
  • Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
  • In Asia Pacific, China ai-based clinical trials solution provider market is projected to lead the regional market in terms of revenue in 2030.
  • Australia is the fastest growing regional market in Asia Pacific and is projected to reach USD 123.2 million by 2030.

No credit card required*

Horizon in a snapshot

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more

AI-based Clinical Trials Solution Provider Market Scope

Ai-based clinical trials solution provider market segmentation & scope
Oncology
CVD
Neurological Diseases or conditions
Metabolic diseases
Infectious diseases
Others
Phase-I
Phase-II
Phase-III
Pharmaceutical Companies
Academia
Others

AI-based Clinical Trials Solution Provider Market Companies

Name Profile # Employees HQ Website

Japan ai-based clinical trials solution provider market outlook

The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to ai-based clinical trials solution provider market will help companies and investors design strategic landscapes.


Oncology was the largest segment with a revenue share of 23.26% in 2021. Horizon Databook has segmented the Japan ai-based clinical trials solution provider market based on oncology, cvd, neurological diseases or conditions, metabolic diseases, infectious diseases covering the revenue growth of each sub-segment from 2018 to 2030.


In Japan, there is a large percentage of population above 65 years of age. Hence, the government focuses on areas such as repairing damaged organ, replacing damaged organs with stem cells, and developing better cost-effective medicines.

These factors are also responsible for development of advanced solutions for clinical trials in the country. In addition, Japan is an attractive market for outsourcing for developed nations. The regulatory process is also supportive of faster clinical trial approval.

For instance, clinical trials can be started once the probable benefits are demonstrated by carrying out relatively smaller number of clinical trials. This creates opportunities for companies to enter into the market, thereby supporting local as well as international players providing technology-based solutions for clinical research.

Reasons to subscribe to Japan ai-based clinical trials solution provider market databook:

  • Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
  • Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
  • Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
  • Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
  • Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.

Target buyers of Japan ai-based clinical trials solution provider market databook

  • Our clientele includes a mix of ai-based clinical trials solution provider market companies, investment firms, advisory firms & academic institutions.
  • 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
  • Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
  • The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.

Horizon Databook provides a detailed overview of country-level data and insights on the Japan ai-based clinical trials solution provider market, including forecasts for subscribers. This country databook contains high-level insights into Japan ai-based clinical trials solution provider market from 2018 to 2030, including revenue numbers, major trends, and company profiles.

Partial client list

  • logo

Japan artificial intelligence based clinical trials solution provider market size, by therapeutic applications, 2018-2030 (US$M)

Japan AI-based Clinical Trials Solution Provider Market Share, 2021 & 2030 (US$M)

Japan artificial intelligence based clinical trials solution provider market size, by therapeutic applications, 2018-2030 (US$M)

Sign up - it's easy, and free!

Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our free plan indefinitely.

Explore all plans

Included in Horizon account

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more